169 related articles for article (PubMed ID: 34682270)
21. Species-specific inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid.
Digits JA; Hedstrom L
Biochemistry; 1999 Nov; 38(46):15388-97. PubMed ID: 10563825
[TBL] [Abstract][Full Text] [Related]
22. Individualization of Mycophenolic Acid Therapy through Pharmacogenetic, Pharmacokinetic and Pharmacodynamic Testing.
Winnicki W; Fichtenbaum A; Mitulovič G; Herkner H; Regele F; Baier M; Zelzer S; Wagner L; Sengoelge G
Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359401
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous quantification of IMPDH activity and purine bases in lymphocytes using LC-MS/MS: assessment of biomarker responses to mycophenolic acid.
Vethe NT; Ali AM; Reine PA; Andersen AM; Bremer S; Line PD; Rootwelt H; Bergan S
Ther Drug Monit; 2014 Feb; 36(1):108-18. PubMed ID: 24061448
[TBL] [Abstract][Full Text] [Related]
24. A Multicenter Case-control Study of the Effect of Acute Rejection and Cytomegalovirus Infection on Pneumocystis Pneumonia in Solid Organ Transplant Recipients.
Hosseini-Moghaddam SM; Shokoohi M; Singh G; Dufresne SF; Boucher A; Jevnikar A; Prasad GVR; Shoker A; Kabbani D; Hebert MJ; Cardinal H; Houde I; Humar A; Kumar D
Clin Infect Dis; 2019 Apr; 68(8):1320-1326. PubMed ID: 30107568
[TBL] [Abstract][Full Text] [Related]
25. Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy.
Vethe NT; Bergan S
Ther Drug Monit; 2006 Oct; 28(5):608-13. PubMed ID: 17038874
[TBL] [Abstract][Full Text] [Related]
26. Plasma and intracellular pharmacokinetic-pharmacodynamic analysis of mycophenolic acid in de novo kidney transplant patients.
Thi MT; Mourad M; Capron A; Tshinanu FM; Vincent MF; Wallemacq P
Clin Biochem; 2015 Apr; 48(6):401-5. PubMed ID: 25523299
[TBL] [Abstract][Full Text] [Related]
27. Mycophenolic acid concentrations in peripheral blood mononuclear cells are associated with the incidence of rejection in renal transplant recipients.
Md Dom ZI; Coller JK; Carroll RP; Tuke J; McWhinney BC; Somogyi AA; Sallustio BC
Br J Clin Pharmacol; 2018 Oct; 84(10):2433-2442. PubMed ID: 29974488
[TBL] [Abstract][Full Text] [Related]
28. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.
Mitsuhashi S; Takenaka J; Iwamori K; Nakajima N; Ubukata M
Bioorg Med Chem; 2010 Nov; 18(22):8106-11. PubMed ID: 20934342
[TBL] [Abstract][Full Text] [Related]
29. Optimization and application of an HPLC method for quantification of inosine-5'-monophosphate dehydrogenase activity as a pharmacodynamic biomarker of mycophenolic acid in Chinese renal transplant patients.
Liu F; Xu L; Sheng C; Qiu X; Zhang M; Jiao Z
Clin Chim Acta; 2018 Oct; 485():333-339. PubMed ID: 29964005
[TBL] [Abstract][Full Text] [Related]
30. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
[TBL] [Abstract][Full Text] [Related]
31. Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients - a pilot study.
Bremer S; Vethe NT; Rootwelt H; Jørgensen PF; Stenstrøm J; Holdaas H; Midtvedt K; Bergan S
J Transl Med; 2009 Jul; 7():64. PubMed ID: 19635156
[TBL] [Abstract][Full Text] [Related]
32. Late-Onset Granulomatous
Baek YJ; Kim K; Nam BD; Jung J; Lee E; Noh H; Kim TH
Infect Chemother; 2023 Sep; 55(3):309-316. PubMed ID: 37794576
[TBL] [Abstract][Full Text] [Related]
33. The pharmacokinetics and pharmacodynamics of mycophenolate mofetil in younger and elderly renal transplant recipients.
Tang JT; de Winter BC; Hesselink DA; Sombogaard F; Wang LL; van Gelder T
Br J Clin Pharmacol; 2017 Apr; 83(4):812-822. PubMed ID: 27753146
[TBL] [Abstract][Full Text] [Related]
34. An exploratory study on pharmacogenetics of inosine-monophosphate dehydrogenase II in peripheral mononuclear cells from liver-transplant recipients.
Vannozzi F; Filipponi F; Di Paolo A; Danesi R; Urbani L; Bocci G; Catalano G; De Simone P; Mosca F; Del Tacca M
Transplant Proc; 2004 Nov; 36(9):2787-90. PubMed ID: 15621150
[TBL] [Abstract][Full Text] [Related]
35. Six-month risk of Pneumocystis pneumonia following acute cellular rejection: A case-control study in solid organ transplant recipients.
Hosseini-Moghaddam SM; Shokoohi M; Singh G; Nagpal AD; Jevnikar AM
Clin Transplant; 2021 Jul; 35(7):e14322. PubMed ID: 33882151
[TBL] [Abstract][Full Text] [Related]
36. Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: potential clinical implications.
Weimert NA; Derotte M; Alloway RR; Woodle ES; Vinks AA
Ther Drug Monit; 2007 Apr; 29(2):141-9. PubMed ID: 17417067
[TBL] [Abstract][Full Text] [Related]
37. Highly Conserved
Bonnet PL; Le Gal S; Hoffmann CV; Morio F; Diabira F; de Quélen A; Curral G; Negri S; Cogulet V; Huon JF; Grégoire M; Papon N; Le Pape P; Bouchara JP; Nevez G
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0156321. PubMed ID: 34723629
[TBL] [Abstract][Full Text] [Related]
38.
Iriart X; Bouar ML; Kamar N; Berry A
J Fungi (Basel); 2015 Sep; 1(3):293-331. PubMed ID: 29376913
[No Abstract] [Full Text] [Related]
39. Adaptive evolution of drug targets in producer and non-producer organisms.
Hansen BG; Sun XE; Genee HJ; Kaas CS; Nielsen JB; Mortensen UH; Frisvad JC; Hedstrom L
Biochem J; 2012 Jan; 441(1):219-26. PubMed ID: 21916847
[TBL] [Abstract][Full Text] [Related]
40. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients.
Langman LJ; LeGatt DF; Halloran PF; Yatscoff RW
Transplantation; 1996 Sep; 62(5):666-72. PubMed ID: 8830834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
